SCHEMBL30644877

SCHEMBL30644877

CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1ccc(O)cc1)[C@@H](C)O)[C@@H](C)CC)[C@@H](C)CC)C(=O)O

nearest known ligand 0.61

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ BACE1 P56817 1/20 0.60
▸ GLP1R P43220 6/20 0.55
▸ CCKBR P32239 1/20 0.55
▸ CALCR P30988 3/20 0.54
▸ CRHR1 P34998 1/20 0.54
▸ CRHR2 Q13324 1/20 0.54
▸ VIPR1 P32241 2/20 0.54
▸ VIPR2 P41587 2/20 0.53
▸ OPRL1 P41146 1/20 0.53
▸ ECE1 P42892 1/20 0.52
▸ MUS81 Q96NY9 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31098023 0.93 OPRD1 (0.60) BACE1GLP1RCCKBRECE1MUS81
SCHEMBL11564811 0.90 OPRD1 (0.56) BACE1OPRL1
SCHEMBL31038686 0.90 OPRD1 (0.58) BACE1GLP1RCCKBRECE1MUS81
SCHEMBL31098050 0.90 CALCR (0.65) GLP1RCALCRCRHR1CRHR2
SCHEMBL11589163 0.89 OPRL1 (0.56) GLP1RCRHR1CRHR2OPRL1
SCHEMBL30512625 0.89 BACE1 (0.57) BACE1OPRL1
SCHEMBL11661183 0.88 OPRL1 (0.56) BACE1GLP1RCRHR1CRHR2OPRL1
SCHEMBL31575683 0.88 VIPR1 (0.61) BACE1GLP1RCCKBRCALCRCRHR1
SCHEMBL30432126 0.88 CALCR (0.68) GLP1RCALCRCRHR1CRHR2
SCHEMBL30431778 0.88 GLP1R (0.59) BACE1GLP1RCCKBRCALCRCRHR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023207106-A1 GLP-1/GIP RECEPTOR CO-AGONIST, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND USE THEREOF 苏州星洲生物科技有限公司 2023-11-02 — — WO disclosed
Send feedback